Identifying the Optimal Breast Cancer Screening Interval
A meta-analysis of data from randomized clinical trials into breast cancer screening showed that women aged 50 to 70 years invited to...
New Method Combines X-rays with Harmless Red Light for Improved Breast Cancer Diagnosis
A new advance in optical mammography, coupling harmless red or infrared light with X-rays, increases the sensitivity of the approach for...
Researchers See Uptick in Size of Breast Cancer Tumors at Diagnosis
Researchers say the size of breast tumors at diagnosis has decreased since routine screening came along, but they’re getting bigger....
How 23andMe Quelled FDA Concerns About DTC Breast Cancer Gene Test
When the FDA approved 23andMe’s direct-to-consumer test for some BRCA1/BRCA2 gene mutations on March 6, it did so with caveats. The test,...
Study Reveals a Strategy to Reduce Heart Damage Linked to the Breast Cancer Drug Herceptin
Breast cancer patients who take either of two heart medicines while undergoing treatment with Herceptin (trastuzumab) were not protected...
FDA OKs First At-home Genetic Test for Breast Cancer Risk
U.S. regulators have approved the first genetic test a woman can take at home to check her risk of developing breast cancer — but its...